How well do people living with neurodegenerative diseases manage their finances? A meta-analysis and systematic review on the capacity to make financial decisions in people living with neurodegenerative diseases

Neurosci Biobehav Rev. 2021 Aug:127:709-739. doi: 10.1016/j.neubiorev.2021.05.021. Epub 2021 May 28.

Abstract

Self and proxy reported questionnaires indicate that people living with a neurodegenerative disease (NDD) have more difficulties with financial decision-making (FDM) than healthy controls. Self-reports, however, rely on adequate insight into everyday functioning and might, therefore, be less reliable. The present study provides a comprehensive overview and meta-analysis of studies evaluating FDM in people living with an NDD. For this, the reliability of performance-based tests to consistently identify FDM difficulties in people living with an NDD compared to healthy controls is evaluated. Furthermore, the associations between FDM and disease severity, performances on standard measures of cognition and demographics are evaluated. All 47 included articles, consistently reported lower performances on performance-based FDM tests of people living with an NDD (including Alzheimer's disease, mild cognitive impairment, frontotemporal dementia, Parkinson's disease, multiple sclerosis or Huntington's disease) compared to healthy controls. The majority of studies, however, focused on Alzheimer's disease and mild cognitive impairment (k = 38). FDM performance appears to be related to cognitive decline, specifically in working memory, processing speed and numeracy.

Keywords: Alzheimer’s disease; Cognition; Finances; Financial capability; Financial capacity; Financial competence; Financial decision-making; Frontotemporal Dementia; Huntington’s disease; Mild cognitive impairment; Monetary; Money management; Multiple sclerosis; Neurodegenerative diseases; Parkinson’s disease.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Alzheimer Disease*
  • Cognition
  • Cognitive Dysfunction*
  • Humans
  • Huntington Disease*
  • Neurodegenerative Diseases*
  • Reproducibility of Results